|
UY35044A
(en)
*
|
2012-09-24 |
2014-04-30 |
Gilead Sciences Inc |
ANTI-dDr1 ANTIBODIES
|
|
AU2014354769A1
(en)
|
2013-11-26 |
2016-05-26 |
Gilead Sciences, Inc. |
Therapies for treating myeloproliferative disorders
|
|
AU2015206194A1
(en)
|
2014-01-20 |
2016-07-28 |
Gilead Sciences, Inc. |
Therapies for treating cancers
|
|
TW201639573A
(en)
|
2015-02-03 |
2016-11-16 |
吉李德科學股份有限公司 |
Combination therapies for treating cancers
|
|
EP3722297A1
(en)
|
2015-03-04 |
2020-10-14 |
Gilead Sciences, Inc. |
Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
|
|
ES2900482T3
(en)
|
2015-10-01 |
2022-03-17 |
Gilead Sciences Inc |
Combination of a Btk inhibitor and a checkpoint inhibitor for cancer treatment
|
|
EP3394044A1
(en)
|
2015-12-17 |
2018-10-31 |
Gilead Sciences, Inc. |
Tank-binding kinase inhibitor compounds
|
|
JP2019510752A
(en)
|
2016-03-04 |
2019-04-18 |
ギリアード サイエンシーズ， インコーポレイテッド |
Compositions and combinations of autotaxin inhibitors
|
|
WO2017177179A1
(en)
|
2016-04-08 |
2017-10-12 |
Gilead Sciences, Inc. |
Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
|
|
MX2018015584A
(en)
|
2016-06-13 |
2019-09-18 |
I Mab |
Anti-pd-l1 antibodies and uses thereof.
|
|
WO2018026835A1
(en)
|
2016-08-04 |
2018-02-08 |
Gilead Sciences, Inc. |
Cobicistat for use in cancer treatments
|
|
PT3507276T
(en)
|
2016-09-02 |
2022-01-11 |
Gilead Sciences Inc |
TOLL-TYPE RECEIVER MODULATING COMPOUNDS
|
|
EP3507288B1
(en)
|
2016-09-02 |
2020-08-26 |
Gilead Sciences, Inc. |
4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
|
|
US20180133212A1
(en)
|
2016-11-03 |
2018-05-17 |
Gilead Sciences, Inc. |
Combination of a bcl-2 inhibitor and a bromodomain inhibitor for treating cancer
|
|
WO2018083237A1
(en)
*
|
2016-11-03 |
2018-05-11 |
Roche Diagnostics Operations Inc. |
Novel anti-py520-ddr1 antibodies
|
|
WO2018083240A1
(en)
*
|
2016-11-03 |
2018-05-11 |
Roche Diagnostics Gmbh |
Novel anti-py796-ddr1 antibodies
|
|
WO2018083238A1
(en)
*
|
2016-11-03 |
2018-05-11 |
Roche Diagnostics Gmbh |
Novel anti-py792-ddr1 antibodies
|
|
WO2018097977A1
(en)
|
2016-11-22 |
2018-05-31 |
Gilead Sciences, Inc. |
Crystalline forms of a phosphate complex of a bet inhibitor
|
|
SI3383916T1
(en)
|
2017-01-24 |
2022-06-30 |
I-Mab Biopharma Us Limited |
Anti-CD73 antibodies and their uses
|
|
US10314844B2
(en)
|
2017-02-24 |
2019-06-11 |
Gilead Sciences, Inc. |
Inhibitors of Bruton's tyrosine kinase
|
|
US10370381B2
(en)
|
2017-02-24 |
2019-08-06 |
Gilead Sciences, Inc. |
Inhibitors of bruton'S tyrosine kinase
|
|
JOP20180040A1
(en)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
Pd-1/pd-l1 inhibitors
|
|
CN111566120B
(en)
|
2017-12-20 |
2023-09-29 |
捷克共和国有机化学与生物化学研究所 |
3’3’ cyclic dinucleotide with phosphonate bond that activates STING adapter protein
|
|
US11203610B2
(en)
|
2017-12-20 |
2021-12-21 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
CR20200347A
(en)
|
2018-02-13 |
2020-09-23 |
Gilead Sciences Inc |
Pd-1/pd-l1 inhibitors
|
|
TW202005654A
(en)
|
2018-04-06 |
2020-02-01 |
捷克科學院有機化學與生物化學研究所 |
2'2'-cyclic dinucleotides
|
|
TWI833744B
(en)
|
2018-04-06 |
2024-03-01 |
捷克科學院有機化學與生物化學研究所 |
3'3'-cyclic dinucleotides
|
|
TWI818007B
(en)
|
2018-04-06 |
2023-10-11 |
捷克科學院有機化學與生物化學研究所 |
2'3'-cyclic dinucleotides
|
|
KR102591947B1
(en)
|
2018-04-19 |
2023-10-25 |
길리애드 사이언시즈, 인코포레이티드 |
PD-1/PD-L1 inhibitors
|
|
WO2019211799A1
(en)
|
2018-05-03 |
2019-11-07 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide
|
|
EP3814272A4
(en)
|
2018-05-11 |
2022-03-02 |
Phosphorex, Inc. |
MICROPARTICLES AND NANOPARTICLES WITH NEGATIVE SURFACE CHARGES
|
|
WO2019222112A1
(en)
|
2018-05-14 |
2019-11-21 |
Gilead Sciences, Inc. |
Mcl-1 inhibitors
|
|
PT3820572T
(en)
|
2018-07-13 |
2023-11-10 |
Gilead Sciences Inc |
Pd-1/pd-l1 inhibitors
|
|
WO2020072656A1
(en)
|
2018-10-03 |
2020-04-09 |
Gilead Sciences, Inc. |
Imidozopyrimidine derivatives
|
|
JP7158577B2
(en)
|
2018-10-24 |
2022-10-21 |
ギリアード サイエンシーズ， インコーポレイテッド |
PD-1/PD-L1 inhibitor
|
|
KR102658602B1
(en)
|
2018-10-31 |
2024-04-19 |
길리애드 사이언시즈, 인코포레이티드 |
Substituted 6-azabenzimidazole compounds with HPK1 inhibitory activity
|
|
EP4371987B9
(en)
|
2018-10-31 |
2025-11-26 |
Gilead Sciences, Inc. |
Substituted 6-azabenzimidazole compounds as hpk1 inhibitors
|
|
US20220143061A1
(en)
|
2019-03-07 |
2022-05-12 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
3'3'-cyclic dinucleotides and prodrugs thereof
|
|
CN113543851B
(en)
|
2019-03-07 |
2025-03-18 |
捷克共和国有机化学与生物化学研究所 |
2'3'-Cyclic dinucleotides and prodrugs thereof
|
|
EP3935065A1
(en)
|
2019-03-07 |
2022-01-12 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator
|
|
TW202210480A
(en)
|
2019-04-17 |
2022-03-16 |
美商基利科學股份有限公司 |
Solid forms of a toll-like receptor modulator
|
|
TWI751517B
(en)
|
2019-04-17 |
2022-01-01 |
美商基利科學股份有限公司 |
Solid forms of a toll-like receptor modulator
|
|
WO2020237025A1
(en)
|
2019-05-23 |
2020-11-26 |
Gilead Sciences, Inc. |
Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors
|
|
CA3140708A1
(en)
|
2019-06-18 |
2020-12-24 |
Helen Horton |
Combination of hepatitis b virus (hbv) vaccines and pyridopyrimidine derivatives
|
|
WO2020263830A1
(en)
|
2019-06-25 |
2020-12-30 |
Gilead Sciences, Inc. |
Flt3l-fc fusion proteins and methods of use
|
|
CN118178645A
(en)
|
2019-10-18 |
2024-06-14 |
四十七公司 |
Combination therapy for the treatment of myelodysplastic syndrome and acute myeloid leukemia
|
|
KR20220091576A
(en)
|
2019-10-31 |
2022-06-30 |
포티 세븐, 인코포레이티드 |
Anti-CD47 and Anti-CD20 Based Treatment of Hematological Cancers
|
|
TWI778443B
(en)
|
2019-11-12 |
2022-09-21 |
美商基利科學股份有限公司 |
Mcl1 inhibitors
|
|
JP2023508277A
(en)
|
2019-12-17 |
2023-03-02 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
Novel DDR1 antibodies and uses thereof
|
|
HRP20241518T1
(en)
|
2019-12-24 |
2025-01-03 |
Carna Biosciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
PH12022552122A1
(en)
|
2020-02-14 |
2024-01-29 |
Jounce Therapeutics Inc |
Antibodies and fusion proteins that bind to ccr8 and uses thereof
|
|
US12110294B2
(en)
|
2020-05-01 |
2024-10-08 |
Gilead Sciences, Inc. |
CD73 compounds
|
|
TW202302145A
(en)
|
2021-04-14 |
2023-01-16 |
美商基利科學股份有限公司 |
Co-inhibition of cd47/sirpα binding and nedd8-activating enzyme e1 regulatory subunit for the treatment of cancer
|
|
WO2022245671A1
(en)
|
2021-05-18 |
2022-11-24 |
Gilead Sciences, Inc. |
Methods of using flt3l-fc fusion proteins
|
|
WO2022255440A1
(en)
*
|
2021-06-04 |
2022-12-08 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-ddr2 antibodies and uses thereof
|
|
WO2022271659A1
(en)
|
2021-06-23 |
2022-12-29 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
US11932634B2
(en)
|
2021-06-23 |
2024-03-19 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
US11976072B2
(en)
|
2021-06-23 |
2024-05-07 |
Gilead Sciences, Inc. |
Diacylglycerol kinase modulating compounds
|
|
EP4359413A1
(en)
|
2021-06-23 |
2024-05-01 |
Gilead Sciences, Inc. |
Diacylglyercol kinase modulating compounds
|
|
US20230183216A1
(en)
|
2021-10-28 |
2023-06-15 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
|
CR20240173A
(en)
|
2021-10-29 |
2024-06-20 |
Gilead Sciences Inc |
CD73 COMPOUNDS
|
|
US20230203202A1
(en)
|
2021-12-08 |
2023-06-29 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and 5t4
|
|
WO2023107954A1
(en)
|
2021-12-08 |
2023-06-15 |
Dragonfly Therapeutics, Inc. |
Antibodies targeting 5t4 and uses thereof
|
|
CN118488948A
(en)
|
2021-12-22 |
2024-08-13 |
吉利德科学公司 |
IKAROS zinc finger family degraders and their uses
|
|
JP2024546851A
(en)
|
2021-12-22 |
2024-12-26 |
ギリアード サイエンシーズ， インコーポレイテッド |
IKAROS ZINC FINGER FAMILY DEGRADANT AND USES THEREOF
|
|
TW202340168A
(en)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Parp7 inhibitors
|
|
JP2025509610A
(en)
|
2022-03-17 |
2025-04-11 |
ギリアード サイエンシーズ， インコーポレイテッド |
IKAROS ZINC FINGER FAMILY DEGRADANT AND USES THEREOF
|
|
WO2023183817A1
(en)
|
2022-03-24 |
2023-09-28 |
Gilead Sciences, Inc. |
Combination therapy for treating trop-2 expressing cancers
|
|
TWI876305B
(en)
|
2022-04-05 |
2025-03-11 |
美商基利科學股份有限公司 |
Combination therapy for treating colorectal cancer
|
|
JP2025513258A
(en)
|
2022-04-21 |
2025-04-24 |
ギリアード サイエンシーズ， インコーポレイテッド |
KRA G12D modulating compounds
|
|
IL317958A
(en)
|
2022-07-01 |
2025-02-01 |
Gilead Sciences Inc |
Cd73 compounds
|
|
JP2025528772A
(en)
*
|
2022-08-03 |
2025-09-02 |
菲柏生物医学技術（広州）有限公司 |
Anti-DDR2 nanobodies and uses thereof
|
|
CN116027038A
(en)
*
|
2022-09-16 |
2023-04-28 |
菲创生物医学技术(广州)有限公司 |
Use of discoid domain receptor 2 in the diagnosis of glioma and related computer readable medium
|
|
US20240091351A1
(en)
|
2022-09-21 |
2024-03-21 |
Gilead Sciences, Inc. |
FOCAL IONIZING RADIATION AND CD47/SIRPa DISRUPTION ANTICANCER COMBINATION THERAPY
|
|
CN116023497B
(en)
*
|
2022-11-09 |
2024-06-21 |
四川大学华西医院 |
Anti-DDR1 antibodies and uses thereof
|
|
KR20250122479A
(en)
|
2022-12-22 |
2025-08-13 |
길리애드 사이언시즈, 인코포레이티드 |
PRMT5 inhibitors and uses thereof
|
|
CN120882725A
(en)
|
2023-04-11 |
2025-10-31 |
吉利德科学公司 |
KRAS-regulated compounds
|
|
CN121079300A
(en)
|
2023-04-21 |
2025-12-05 |
吉利德科学公司 |
PRMT5 inhibitors and their uses
|
|
WO2025006720A1
(en)
|
2023-06-30 |
2025-01-02 |
Gilead Sciences, Inc. |
Kras modulating compounds
|
|
WO2025024811A1
(en)
|
2023-07-26 |
2025-01-30 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
WO2025024663A1
(en)
|
2023-07-26 |
2025-01-30 |
Gilead Sciences, Inc. |
Parp7 inhibitors
|
|
US20250109147A1
(en)
|
2023-09-08 |
2025-04-03 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
US20250101042A1
(en)
|
2023-09-08 |
2025-03-27 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
|
WO2025096589A1
(en)
|
2023-11-03 |
2025-05-08 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
US20250376484A1
(en)
|
2024-05-21 |
2025-12-11 |
Gilead Sciences, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CN118909125B
(en)
*
|
2024-10-10 |
2025-01-03 |
杭州美赛生物医药科技有限公司 |
Anti-DDR1 antibodies and their applications
|